Recent reports suggest that PTX3 was implicated as a new diagnostic biomarker of vascular disease in type 2 diabetes mellitus and diabetic cardiac dysfunction after myocardial infarction (Salio et al., 2008, Trojak et al., 2019). This evidence concerns the gene PTX3 and myocardial infarction.